Escuela de Kinesiología, Facultad de Salud, Universidad Santo Tomás, Chile.
Physiotherapy in Motion Multispeciality Research Group (PTinMOTION), Department of Physiotherapy, University of Valencia, Valencia, Spain; Department of Physical Therapy, Faculty of Medicine, University of Chile, Santiago, Chile.
Physiotherapy. 2024 Dec;125:101418. doi: 10.1016/j.physio.2024.101418. Epub 2024 Aug 3.
To determine the optimal dose and short-term effectiveness of kinesiotaping (KT) on pain intensity and disability in pregnant women with lumbo-pelvic pain.
MEDLINE (via PubMed Central), CINAHL, Epistemonikos, Scopus, and Web of Science from inception to 21st March 2023.
We included randomized controlled trials (RCT) conducted on pregnant women with lumbo-pelvic pain treated with KT.
The outcomes included pain intensity and disability. ROB-2 and GRADE were used to assess the risk of bias and the certainty of the evidence, respectively. A random effects meta-analysis was performed using the standardized mean difference (SMD) and the corresponding 95% confidence interval (CI). The dose-response association was evaluated using a restricted cubic spline model.
Seven RCTs involving 527 patients were included. Meta-analysis revealed a statistically significant effect in favor of KT on pain intensity (SMD = -1.71; 95% CI = -2.51 to -0.90; P = <0.001) and on disability (SMD = -1.15; 95% CI = -2.29 to -0.02; P = <0.001). The total duration of KT use ranged from 5 to 35 days. It was estimated that a dose of 5-10 days exceeded the minimal clinically important difference (MCID) for pain intensity (mean difference at 10 days = -2.63; 95% CI = -3.05 to -2.22). Low certainty of evidence was identified for both outcomes.
In pregnant women with lumbo-pelvic pain, the use of KT for 5 to 10 days produces a short-term reduction in pain intensity that exceeds the MCID, with a low certainty of evidence.
Systematic Review Registration Number PROSPERO CRD42023388174. CONTRIBUTION OF PAPER.
确定运动贴扎(KT)治疗腰骨盆疼痛孕妇的最佳剂量和短期疗效,以减轻疼痛强度和改善残疾状况。
通过 PubMed Central 检索 MEDLINE、CINAHL、Epistemonikos、Scopus 和 Web of Science,检索时间截至 2023 年 3 月 21 日。
纳入了针对腰骨盆疼痛孕妇进行 KT 治疗的随机对照试验(RCT)。
结局指标包括疼痛强度和残疾。使用 ROB-2 和 GRADE 分别评估偏倚风险和证据质量。使用标准化均数差(SMD)及其相应的 95%置信区间(CI)进行随机效应荟萃分析。使用限制立方样条模型评估剂量-反应关系。
纳入了 7 项 RCT,共涉及 527 名患者。荟萃分析结果显示,KT 对疼痛强度(SMD=-1.71,95%CI=-2.51 至-0.90;P<0.001)和残疾(SMD=-1.15,95%CI=-2.29 至-0.02;P<0.001)均有统计学意义。KT 总使用时间为 5-35 天。估计 5-10 天的剂量超过疼痛强度的最小临床重要差异(MCID)(第 10 天的平均差异=2.63,95%CI=3.05 至 2.22)。两个结局的证据质量均为低级别。
对于腰骨盆疼痛的孕妇,使用 KT 治疗 5-10 天可在短期内降低疼痛强度,且超过 MCID,证据质量为低级别。
PROSPERO CRD42023388174。
论文贡献。